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Abstract: Hypertension has been estimated to complicate 5 % of all pregnancies, with 
hypertensive disorders accounting for up to 40 000 maternal deaths annually. This study 
therefore seeks to investigate the effect hypertension has on some serum metabolites, namely; 
Serum 25-OH vitamin D (Vit. D), Alkaline phosphates (ALP), Inorganic phosphates (Pi), 
Calcium and Total protein level in hypertensive and non-hypertensive pregnant women at 
different gestation period/ trimesters. Vit. D was assayed by Elisa, while the other parameters 
were all assayed by colorimetric method. Vit. D, Calcium, Pi and total protein had their highest 
values at non-hypertensive (control) conditions at all trimesters, while other hypertensive 
conditions from severe, mild to pre-hypertensive cases had steady increase in all the serum 
metabolites above mentioned except for Pi, which showed a sharp increase in its value between 
the mild and pre-hypertensive at all three stages studied: 0.09 ± 0.01 and 1.45± 0.12mmol/L at 
first trimester,0.087±0.01 and 1.23±0.12 mmol/L at second trimester, whileat third trimester 
0.07±0.01 and 1.03±0.12 mmol/L. However ALP showed different pattern with its highest mean 
enzyme activity observed for severe hypertensive cases;192.47±13.11U/L at first trimester, 
197.32±18.11U/L at second trimester and 212.47±21.71 U/L at third trimester. Therefore, all the 
serum metabolites understudied showed significant relationship in the values obtained from the 
hypertensive and non-hypertensive patients considered and can serve as possible inference for 
early diagnosis of maternal and foetal complications in hypertension. 
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1. INTRODUCTION 
 Pregnancy, also known as gravidity or gestation, is the time during which one or more 
offspring develops inside a woman and at this period, maternal physiological changes happen. 
During pregnancy, there are changes in metabolic, biochemical, physiological, haematological 
and immunological processes and if there are no complications, all these changes are reversible a 
few days to a few months after delivery (Sonagra et al., 2012). Globally, an estimated 500,000 
women die from complications arising during pregnancy, delivery or puerperium while in 
Nigeria, a total of 55,000 die which accounts for 10 % of the world’s total deaths while Nigeria 
is 2 % of world’s population (Nwosu et al., 2009). Hypertensive disorders of pregnancy (HDP) 
and their complications rank as one of the major cause of maternal mortality and morbidity in the 
world after obstetric haemorrhage, pre-existing medical disorders, sepsis and abortions (Park, 
2011). It is also reported to complicate 1 in 10 pregnancies hence it is the most common medical 
disorder of pregnancy in both developing and developed countries (Magee and Von Dadelszen, 
2004; Podymow and August, 2008). Kamath (2006), reported that HDP occurs in approximately 
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6-8% of all pregnancies, 10% of first pregnancies, and 20-25% of women with a history of 
chronic hypertension, while it also accounts for a quarter of all antenatal admissions as it has 
been associated with fetal growth retardation and leading to largely to perinatal mortality and 
morbidity (Bansal, 2008; Datta, 2011). 
 
 It is also known that maternal nutrition during pregnancy exerts profound effect on the health 
of both mother and child. Hence a thorough research on all the biochemical changes is thus 
necessary in order to understand the pathophysiology and identification of biochemical markers 
that help in early diagnosis of the disorder. This will help in reducing the risk women face in 
preventing hypertension in subsequent pregnancies and later in their life. This study tried to 
investigate the effect of hypertension during pregnancy on serum 25-OH vitamin D, Alkaline 
Phosphates, Inorganic phosphates, calcium and Total Protein and to ascertain any possible 
correlation. 
 
2. MATERIALS AND METHODS 
 The study was carried out in State specialist Hospital (SSH) located in Akure, SSH 
Okitipupa, SSH Ikare and Federal Medical Centre (FMC), Owo. The study spanned between 
December 2013 and October 2014. Five hundred pregnant women of different trimesters were 
recruited according to their blood pressure and their samples were collected for the study. They 
were categorized into four groups of blood pressure. One hundred normotensive (< 120/<80) 
were used as the control while four hundred that were hypertensive were in three groups of blood 
pressure. The severe hypertensive blood pressure (≥160/ ≥100), mild hypertensive blood 
pressure (140-159/90-99) and pre hypertensive blood pressure (120-139/80-89). The pregnant 
women were within the age range of 26 to 43 years. 
 
 Blood sample which was collected from all the subjects three times from the first trimester 
(1– 3months) to the third trimester (6 – 9 months) of the subjects using method as described by 
Monica (2000). About 3 ml of blood were collected into sterileplain bottles at each collection 
period and the serum was pooled 3hours after collection and stored at < –4 ºC before analysis. 
 
 Alkaline Phosphatase assay was carried out using colorimetric method, with readings taken 
at 550 nm wavelength (Babson et al., 1966). Assay of Inorganic Phosphate was done using 
standard method of Debruyne (1983) and absorbance read on the spectrophotometer was at a 
wavelength of 340 nm. The assay of Calcium using the method of Fogh-Andersen et al., (1978); 
the preparations in each of the tubes were mixed and read at a wavelength of 600 nm against the 
reagent blank after 5 minutes of preparation. Vitamin D3assay was carried out by using Elisa 
(Enzyme linked immunosorbent Assay) (Randox, UK). The intensity of the yellow colouration 
obtained is indirectly proportional to the concentration of 25-Hydroxy Vitamin D in the sample. 
The absorbance was determined with an Elisa reader at 450 nm against 620 nm (Zerwekh, 2008), 
while the assay of Total protein was carried out according to Biuret method (Layne, 1957). Data 
collected by questionnaire distributed amongst all considered women to obtain further details and 
general knowledge pertaining to their blood pressure state and previous medical history, was also 
analysed. 
3. RESULTS AND DISCUSSION 
 The relationship between the serum metabolite – Alkaline phosphatises (ALP) of pregnant 
women and their blood pressure at different stages of pregnancy was represented in Figure 1.  
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Figure 1: Alkaline Phosphatase (ALP) of pregnant women and their blood pressure at different 
stages of pregnancy 
  
 Steady increase in placental alkaline phosphatase (PALP) was observed at all hypertensive 
stages of pregnancy, control (normotensive) conditions inclusive. Highest mean unit of enzyme 
activity observed was 212.47±21.71 U/L, recorded for severe hypertensive pregnant women in 
their third trimester. A statistical increase at different probability level of ALP was shown in this 
research work. The test groups for each trimester increased with increase in the gestational age of 
the subjects as seen from the results, in reference to the control. This was in agreement with 
Jeacock et al., (1963) which showed that phosphatase activity in the placenta usually increases 
during pregnancy and Sussman and Bowman (1968) validated that claim by showing that 
placental phosphatase first appears in the first trimester of pregnancy and increases during 
gestation to comprise 40 – 67% of the total serum phosphatase during the third trimester. Also 
the increase in ALP can be attributed to the increase in blood pressure of the subjects because 
there is an increase of ALP activity in pre-eclampsia. 
  
 At all hypertensive conditions tested, the mean values of Pi reduced with severity in blood 
pressure considered (figure 2). The highest concentration of Pi been recorded was for control at 
all trimesters;1.83±0.19, 1.85±0.19 and 1.78±0.19mmol/L for first, second and third trimesters 
respectively. Also, mean concentration of Pi reduced at all hypertensive conditions as gestation 
age increases, except in control (normotensive), which had a slight increase at second trimester 
before decline in mean concentration at the last trimester. 
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Figure 2: Inorganic Phosphate (Pi) of pregnant women and their blood pressure at different 
stages of pregnancy 
 Calcium (Ca
2+
) of pregnant women and their blood pressure at different stages of pregnancy 
as observed in figure 3 shows thatat all hypertensive conditions tested, the mean values of Ca
2+
 
reduced with severity in blood pressure considered. The highest concentration of Ca
2+
 been 
recorded was for control at all trimesters;2.67±0.28, 2.42±0.16 and 2.34±0.08 mmol/L for first, 
second and third trimesters respectively. 
 
Figure 3: Calcium (Ca
2+
) of pregnant women and their blood pressure at different stages of 
pregnancy. 
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 It was observed, that there was a steady and marked decrease in the serum levels of both 
factors as gestation age increases that is for inorganic phosphate and serum calcium; while the 
concentration of both parameters, was much lower in severe hypertensive patients with a 
corresponding increase in Mild and pre-hypertensive patients. Following the questionnaire the 
tested patients filled, the calcium intake from different supplements by the subjects appears to be 
less than the amount recommended for pregnant women due to socioeconomic status, this may 
also account for the low concentration as gestation period nears. It is therefore suspected that the 
inadequate dietary intake of calcium possibly contributed to the marked decrease in calcium and 
inorganic phosphate of the subjects. Putting into consideration the work of Seelig, (1980), the 
importance of low serum calcium levels in the pathogenesis of such conditions as in-coordinate 
uterine action, pre-eclampsia and intra-uterine growth retardation should also be considered as a 
possible explanation for the decrease in the serum calcium in for the hypertensive pregnant 
women (test group) when compared to non-hypertensive pregnant women (control). Also Blum 
et al., (2008) confirmed that the possible decrease in serum calcium and inorganic phosphate as 
the gestational age increases might be as a result of their utilization for foetal growth.  
 
 Lower serum calcium and phosphate levels were reported in pregnancy-induced hypertension 
(PIH) compared to normotensive pregnant women by Almasganj et al., (2004). A significant 
correlation between serum calcium and hypertension has been shown in PIH (Nasser and Ziad, 
2011). Gary et al., 2005 and others confirmed that high serum calcium level in pregnancy can 
lead to decreased incidence of preeclampsia and vice versa (Daniel and David, 1994; Gary et al., 
2005). The result obtained in this study was in line with the above claim, as there was a statistical 
decrease in the serum calcium level of different blood pressure category in each trimester when 
compared to the control. Likewise, inorganic phosphate showed same correlation. 
 
 1,25-Dihydroxyvitamin D of pregnant women and their blood pressure at different stages of 
pregnancy is presented in figure 4. The concentration of metabolite steadily reduced as gestation 
period progresses in all hypertensive except in normotensive control which had a slight increase 
in concentration at second trimester (i.e. from 89.21±5.17 to 91.03±7.36 mmol/L), before a final 
drop at the third trimester (87.03±7.36 mmol/L). 
 Serum calcium also has an integral pathogenesis with 1,25-dihydroxyvitamin D. 
Physiologically, 1,25-dihydroxyvitamin D stimulates calcium influx in a variety of cells, 
including vascular smooth muscle cells. This effect is rapid, as it is mediated by vitamin D 
receptor rather than via a classical nuclear-receptor-mediated mechanism. As a consequence, 
1,25-dihydroxyvitamin D exerts a repressor effect, serving to promote contraction and increase 
peripheral vascular resistance. Consequently, low calcium diets, which elicit a 1, 25-
dihydroxyvitamin D response, would be expected to increase blood pressure, whereas high 
calcium diets, by virtue of suppressing 1,25- dihydroxyvitamin D levels, would be expected to 
reduce vascular smooth muscle cell intracellular calcium, peripheral vascular resistance and then 
blood pressure (Zemel, 2001). This fact was validated again by this study showing the decrease 
of 1,25-dihydroxyvitamin D as the blood pressure of the subjects increases in each trimester. 
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Figure 4: 1,25- Dihydroxyvitamin D of pregnant women and their blood pressure at different 
stages of pregnancy 
 Total protein of pregnant women and their blood pressure at different stages of pregnancy 
was shown in figure 5. A continuous decrease in total protein concentration was observed with 
severity in blood pressure of pregnant cases considered. Likewise concentration also decreased 
as gestation period progresses for all categories of hypertensive cases and its control. 
 
Figure 5: Total serum protein of pregnant women and their blood pressure at different stages of 
pregnancy 
 Total serum protein represents the sum of albumin and globulin in broad terms. It was 
significantly reduced in the hypertensive test groups compared to the control. This was in line 
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with the work of Hofmeyr et al., (1991) who showed that total proteins were significantly less 
than those of their internal controls in hypertensive women. In the case of trimesters, the 
decrease in the second trimester is most likely due to decrease in albumin fractions and probably 
hypervolemia which is consistent with pregnancy and consequentially causes dilution effect 
(Mustafa et al., 2012). Moreover due to its molecular weight, albumin is the fraction that is 
normally lost during proteinuria in pregnancy. Thus hypoalbuminaemia in pregnancy may not 
necessarily be due to decrease in production but also dilution (Greenwood et al., 1970). 
 
4. CONCLUSION 
 Since the relationship between the serum metabolites of hypertensive and non-hypertensive 
pregnant women was noteworthy, inference can be drawn from them by medical experts in better 
understanding the pathological process of pregnancy induced hypertension and to develop 
strategies for prevention and early diagnosis of any maternal and foetal complications in 
hypertension. 
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